LifeArc Ventures

corporate vcCo-investsLeads rounds

◆ Check Size

$0.3M→$2.0M

◆ Location

United Kingdom

◆ Portfolio

1 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗@LifeArcVentures on X ↗

◆ Investment Thesis

Direct investment in therapeutics and tech-enabled biotechnology companies across all modalities and therapeutic areas, alongside a fund of funds strategy, to return capital to LifeArc's balance sheet while translating scientific ideas into solutions for patients.

◆ About LifeArc Ventures

LifeArc Ventures invests in early-stage science-led life science companies across therapeutics, HealthTech, and medical devices to drive patient impact and financial returns for LifeArc.

◆ Sectors

BiotechDrug DiscoveryHealthtech InfrastructureMedtechDigital Health

◆ Stages

seedseries-aseries-b

◆ Geography Focus

GermanyScandinaviaSwitzerlandUnited KingdomUnited States

◆ Team

Name	Title	Role	Links
Clare Terlouw	Partner	—	in
Dr Ian Gilham	Chair of Board of Trustees	Board
Etienne Cousin	investment associate	—	in
Jonathan Birt	Partner	—
Mo Noonan	Partner	—
Olivia Cavlan	Partner	—	in

◆ Notable Investments

Fluid Biomed IncCytospire TherapeuticsRQ Biotechnology LtdRQ BioExcivaTribune TherapeuticsHillstar BioMaxion Therapeutics

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does LifeArc Ventures invest in?

LifeArc Ventures invests in Biotech, Drug Discovery, Healthtech Infrastructure, Medtech and Digital Health at the seed, series-a and series-b stages.

Which geographies does LifeArc Ventures focus on?

LifeArc Ventures focuses on Germany, Scandinavia, Switzerland, United Kingdom and United States, and is headquartered in United Kingdom.

What is LifeArc Ventures's typical check size?

LifeArc Ventures typically writes checks of $0.3M to $2M.